What is Gilead Sciences's financing cash flow?

Gilead Sciences (GILD) reported financing cash flow of -$4.24B in Q1 2026.

How has Gilead Sciences's financing cash flow changed year-over-year?

Gilead Sciences's financing cash flow decreased by 23.7% year-over-year, from -$3.43B to -$4.24B.

What is the long-term trend for Gilead Sciences's financing cash flow?

Over 3 years (2021 to 2025), Gilead Sciences's financing cash flow has grown at a -4.4% compound annual growth rate (CAGR), from -$8.88B to -$7.75B.

What does financing cash flow mean?

Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Gilead Sciences GILD Financing Cash Flow

Financing Cash Flow at other companies

Bristol-Myers SquibbBMY

-$1.56B-57.1%

IncyteINCY

$84.82M+769%

ImmunityBio, Inc.IBRX

$223.93M+22,903%

PrecigenPGEN

$109K+116%

AnaptysBio, Inc.ANAB

$1.21M+104%

Iovance Biotherapeutics, Inc.IOVA

$94.34M-34.2%

Other financials

Income statement

See full

Revenue$7.0B+4.4%

Gross profit$5.5B+7.6%

Operating income$2.6B+15.6%

Net income$2.0B+53.7%

EPS (diluted)$1.61+54.8%

Balance sheet

See full

Cash & equivalents$7.6B-3.8%

Total debt$22.2B-11.1%

Total equity$23.5B+22.7%

Total assets$56.3B-0.3%

Cash flow

See full

Operating cash flow$2.5B+44.8%

CapEx$117.0M+12.5%

Free cash flow$2.4B+46.8%

Valuation

See full

Market cap$158.77B+19.1%

Enterprise value$173.32B+13.2%

P/E17.2×-3.9×

P/S5.3×+0.7×

Profitability

See full

Gross margin79.4%+1.1pp

Operating margin34.9%+6.3pp

Net margin31%+10.2pp

FCF margin34.4%+0.1pp

Returns & leverage

See full

Return on equity43.2%+10.7pp

Debt / equity0.9×-0.4×

Current ratio2×+0.6×

Where this comes from

Reported directly by Gilead Sciences in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gilead Sciences's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gilead Sciences's financing cash flow?: Gilead Sciences (GILD) reported financing cash flow of -$4.24B in Q1 2026.
How has Gilead Sciences's financing cash flow changed year-over-year?: Gilead Sciences's financing cash flow decreased by 23.7% year-over-year, from -$3.43B to -$4.24B.
What is the long-term trend for Gilead Sciences's financing cash flow?: Over 3 years (2021 to 2025), Gilead Sciences's financing cash flow has grown at a -4.4% compound annual growth rate (CAGR), from -$8.88B to -$7.75B.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.